64Cu-PSMA I&T(Jiangsu Huayi Nuclear Medicine)

N/A

Report date: 2026/05/13 20:02:10

NME

Base Information

Drug Name64Cu-PSMA I&T(Jiangsu Huayi Nuclear Medicine)

Drug Alias Name铜[64Cu]-PSMA I&TCu-64-PSMA-I&T

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Nuclides > Copper > 64Cu

Mechanisms of ActionProstate-Specific Membrane Antigen modulatorsPositron-emission tomography enhancers

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaIND

Originator CompaniesJiangsu Huayi Nuclear Medicine Co Ltd

China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Huayi Nuclear Medicine Co Ltd

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A